Madrigal Pharmaceuticals (MDGL) EBITDA Margin Growth (1y) (2011 - 2026)
Madrigal Pharmaceuticals (MDGL) EBITDA Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1,276.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Madrigal Pharmaceuticals | 15.79 Bn | 15.56 Bn | - | 2,800.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,800.00 |
| Dec 31, 2025 | 4,628.00 |
| Sep 30, 2025 | 14,738.00 |
| Jun 30, 2025 | 108,820.00 |
| Sep 30, 2012 | -2.87 Mn |
| Jun 30, 2012 | -1.38 Mn |
| Mar 31, 2012 | -894,876.00 |
| Dec 31, 2011 | -825,478.00 |
| Sep 30, 2011 | -43,183.00 |
| Jun 30, 2011 | -542,230.00 |